Western Europe

Demand for sleep aids remains high in 2023. Since the pandemic, an increase in sleep issues due to anxiety, depression, and stress, has spread among a large proportion of the French population. According to Euromonitor International’s Voice of the…

Sleep aids sales are set to see continued growth in 2023. The major disruptions to lifestyles and the increasing economic pressures experienced in the last few years have led to a significant increase in the incidence of stress and anxiety and…

Sleep aids is expected to register moderate current value growth and a slight increase in volume sales in 2023. The war in Ukraine and the resulting energy crisis are pushing up average retail prices. While Danes are now much less concerned about the…

Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…

Retail volume sales of sleep aids are declining for the second year running in 2023. The outbreak of COVID-19 led to increased levels of fear and anxiety in 2020 and 2021 which helped drive record sales of sleep aids. With conditions improving in…

In general, paediatric consumer health recorded strong retail volume growth during the early-to-mid-review period, with the outbreak of Coronavirus (COVID-19) in 2020 providing a particular fillip to demand. However, as the pandemic threat eased, the…

Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…

Over 2023, paediatric consumer health retail current value sales are expected to continue to grow healthily. On the other hand, retail volume development is projected to be marginal-to-moderate, with declines anticipated for paediatric acetaminophen…

Value sales of paediatric consumer health remains positive in 2023. Swiss parents prefer to consult with their health practitioner when it comes to their children, and seek help from professionals before resorting to medical recommendations that lead…

Paediatric consumer health remains a minor part of total consumer health in Sweden. The key reasons for this low share include the fact that children are usually treated with general products (suitable for adults and children) with the appropriate…

Spain’s birth rate continues to fall, thereby reducing the target audience of paediatric consumer health and compounding declining growth rates in 2023. As there are no national policies to support a rise in the country’s birth rate, this trend is…

Paediatric consumer health is still a small category in Portugal with parents/guardians generally preferring to buy products on prescription. Portuguese parents/guardians perceive there to be a higher risk when it comes to their children and will…

The sales performances recorded in each of the categories that comprise paediatric consumer health during 2023 were determined to some extent by the performances recorded in each of these categories in 2020, during the early stages of the COVID-19…

Paediatric consumer health is expected to see strong growth in current value terms in 2023, with most categories projected to post a positive performance in value and volume terms. Volume sales are benefiting from the increase in unit prices…

Paediatric consumer health is performing well in 2023 for the second consecutive year, albeit at a much lower pace of current value growth than in 2022. Ireland witnessed a more intense season of common colds and viruses among children in 2022 as the…

The re-opening of schools and the lifting of COVID-19 restrictions, such as compulsory use of face masks in schools, is leading to strong growth for multiple categories within paediatric consumer health. For example, sales of lice/anti-parasitic…

Having already recorded very dynamic growth in 2022, paediatric cold, cough and allergy remedies continued to register the strongest growth in paediatric consumer health in Germany in 2023, albeit at a much more modest pace. This strong performance…

The pandemic led to a higher containment of flu and bronchiolitis in France due to prolonged home seclusion, which negatively impacted children’s immunity. The impact of this is becoming increasingly evident as young consumers now interact with one…

Paediatric consumer health is set to see significant current value growth in Finland in 2023. There are still many underdeveloped areas in which sales can be increased, especially if new, interesting products enter. These areas include dietary…

Paediatric analgesics saw only modest volume growth in 2023 as a result of a return to pre-pandemic consumption habits. More robust current value growth was partly the result of inflationary pressures due to the ongoing conflict in Ukraine, which has…